Archive - 2 January 2021

• COMMENT | DAP's future path is clear
• LETTER | Cost of dilly-dallying or corruption?
• BASE jumping at women's ministry HQ goes awry
• YOURSAY | Ku Li's Malay citizenship - a flawed and outdated concept
• UK reactivates emergency Covid-19 hospitals, closes London primary schools
• Rejecting Trump veto, Republican-led Senate backs defense bill
• 'Cheap trick': China rebuffs latest Taiwan offer of talks
• COMMENT | The cost we pay for our klepto-economics
• CM calls for calm after Covid-19 surge in Penang
• LETTER | An unconscionable embrace of disease
• S'wak Harapan reaches deal to avoid repeat of 2016 clash, open to talks with PSB
• UPDATED 11.35PM | List of locations affected by Covid-19 (Jan 2)
• S'wak PKR takes on more load, to go after defectors
• Umno ready to face Bersatu in court, shows evidence on member poaching claims
• COMMENT | Integrity is the meat of the matter
• PAS tries to contain fallout over expansion of 4D special draw
• Umno Youth chief urges Bersatu to stop 'stealing', 'buying' their members
• Khaled: PN is directionless, non-Malays reps serve as 'ornaments'
• Reform and renewal within Umno has been forgotten, warns Khaled
• Moratorium for hire purchase loans needs rework, says Anwar
• Muafakat will not be formally registered - Annuar
• Hadi denounces non-PN, Muafakat alliances; Umno MP throws shade over PAS' promise
• Star wants to field Sabahan candidates in peninsula
• Covid-19 (Jan 2): New cases exceed 2,000 for third-consecutive day, 9 deaths
• After leaving PKR, Rembia rep joins Umno
• Record number of MCO violations on first day of 2021
• Zafrul calls on policymakers to set aside differences, focus on rakyat
• Umno may let Muhyiddin have Pagoh, but wants Bersatu out of 3 states
• Covid-19: Social activities lead to emergence of Batu 8 Tambunan cluster
• Sabah BN ready to reduce its allocation of parliamentary seats in GE15
• Bersatu-Umno-PAS tensions heat up, and other news you may have missed
• YOURSAY | Anwar's Catch-22 - working with Mahathir
• India's drugs experts approve AstraZeneca, local Covid-19 vaccines